These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37988650)

  • 1. Human Connection: Oncologist Characteristics and Behaviors Associated With Therapeutic Bonding With Latino Patients With Advanced Cancer.
    Tergas AI; Prigerson HG; Penedo FJ; Maciejewski PK
    JCO Oncol Pract; 2024 Jan; 20(1):111-122. PubMed ID: 37988650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beliefs About Advanced Cancer Curability in Older Patients, Their Caregivers, and Oncologists.
    Loh KP; Mohile SG; Lund JL; Epstein R; Lei L; Culakova E; McHugh C; Wells M; Gilmore N; Mohamed MR; Kamen C; Aarne V; Conlin A; Bearden J; Onitilo A; Wittink M; Dale W; Hurria A; Duberstein P
    Oncologist; 2019 Jun; 24(6):e292-e302. PubMed ID: 31015317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the caregiver-oncologist relationship on caregiver experiences of end-of-life care and bereavement outcomes.
    An AW; Ladwig S; Epstein RM; Prigerson HG; Duberstein PR
    Support Care Cancer; 2020 Sep; 28(9):4219-4225. PubMed ID: 31900620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a Patient-Centered Communication Intervention on Oncologist-Patient Communication, Quality of Life, and Health Care Utilization in Advanced Cancer: The VOICE Randomized Clinical Trial.
    Epstein RM; Duberstein PR; Fenton JJ; Fiscella K; Hoerger M; Tancredi DJ; Xing G; Gramling R; Mohile S; Franks P; Kaesberg P; Plumb S; Cipri CS; Street RL; Shields CG; Back AL; Butow P; Walczak A; Tattersall M; Venuti A; Sullivan P; Robinson M; Hoh B; Lewis L; Kravitz RL
    JAMA Oncol; 2017 Jan; 3(1):92-100. PubMed ID: 27612178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of Patient-Oncologist Prognostic Discordance in Advanced Cancer.
    Gramling R; Fiscella K; Xing G; Hoerger M; Duberstein P; Plumb S; Mohile S; Fenton JJ; Tancredi DJ; Kravitz RL; Epstein RM
    JAMA Oncol; 2016 Nov; 2(11):1421-1426. PubMed ID: 27415765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to Newly Prescribed Diabetes Medications Among Insured Latino and White Patients With Diabetes.
    Fernández A; Quan J; Moffet H; Parker MM; Schillinger D; Karter AJ
    JAMA Intern Med; 2017 Mar; 177(3):371-379. PubMed ID: 28114642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of intensive end-of-life and hospice care in Latino and white advanced cancer patients.
    Loggers ET; Maciejewski PK; Jimenez R; Nilsson M; Paulk E; Stieglitz H; Prigerson HG
    J Palliat Med; 2013 Oct; 16(10):1249-54. PubMed ID: 24053593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between strong patient-oncologist agreement regarding goals of care and aggressive care at end-of-life for patients with advanced cancer.
    Douglas SL; Daly BJ; Lipson AR; Blackstone E
    Support Care Cancer; 2020 Nov; 28(11):5139-5146. PubMed ID: 32060703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalists and oncologists show similar care practices and outcomes for hospitalized late-stage cancer patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks for Treatment.
    Rose JH; O'Toole EE; Dawson NV; Thomas C; Connors AF; Wenger N; Phillips RS; Hamel MB; Reding DT; Cohen HJ; Lynn J
    Med Care; 2000 Nov; 38(11):1103-18. PubMed ID: 11078051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actual and Missed Opportunities for End-of-Life Care Discussions With Oncology Patients: A Qualitative Study.
    Knutzen KE; Sacks OA; Brody-Bizar OC; Murray GF; Jain RH; Holdcroft LA; Alam SS; Liu MA; Pollak KI; Tulsky JA; Barnato AE
    JAMA Netw Open; 2021 Jun; 4(6):e2113193. PubMed ID: 34110395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is There a Relationship between Shared Decision Making and Breast Cancer Patients' Trust in Their Medical Oncologists?
    Engelhardt EG; Smets EMA; Sorial I; Stiggelbout AM; Pieterse AH; Hillen MA
    Med Decis Making; 2020 Jan; 40(1):52-61. PubMed ID: 31789100
    [No Abstract]   [Full Text] [Related]  

  • 12. The Effects of Oncologist Implicit Racial Bias in Racially Discordant Oncology Interactions.
    Penner LA; Dovidio JF; Gonzalez R; Albrecht TL; Chapman R; Foster T; Harper FW; Hagiwara N; Hamel LM; Shields AF; Gadgeel S; Simon MS; Griggs JJ; Eggly S
    J Clin Oncol; 2016 Aug; 34(24):2874-80. PubMed ID: 27325865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoting End-of-Life Discussions in Advanced Cancer: Effects of Patient Coaching and Question Prompt Lists.
    Rodenbach RA; Brandes K; Fiscella K; Kravitz RL; Butow PN; Walczak A; Duberstein PR; Sullivan P; Hoh B; Xing G; Plumb S; Epstein RM
    J Clin Oncol; 2017 Mar; 35(8):842-851. PubMed ID: 28135140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Disparities in Family History and Family Cancer History in the Electronic Health Record With Sex, Race, Hispanic or Latino Ethnicity, and Language Preference in 2 Large US Health Care Systems.
    Chavez-Yenter D; Goodman MS; Chen Y; Chu X; Bradshaw RL; Lorenz Chambers R; Chan PA; Daly BM; Flynn M; Gammon A; Hess R; Kessler C; Kohlmann WK; Mann DM; Monahan R; Peel S; Kawamoto K; Del Fiol G; Sigireddi M; Buys SS; Ginsburg O; Kaphingst KA
    JAMA Netw Open; 2022 Oct; 5(10):e2234574. PubMed ID: 36194411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncologist phenotypes and associations with response to a machine learning-based intervention to increase advance care planning: Secondary analysis of a randomized clinical trial.
    Li E; Manz C; Liu M; Chen J; Chivers C; Braun J; Schuchter LM; Kumar P; Patel MS; Shulman LN; Parikh RB
    PLoS One; 2022; 17(5):e0267012. PubMed ID: 35622812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facilitators Associated With Building and Sustaining Therapeutic Alliance in Advanced Pediatric Cancer.
    Kaye EC; Rockwell S; Woods C; Lemmon ME; Andes K; Baker JN; Mack JW
    JAMA Netw Open; 2021 Aug; 4(8):e2120925. PubMed ID: 34415315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facilitators and Barriers to Oncologists' Conduct of Goals of Care Conversations.
    Schulman-Green D; Lin JJ; Smith CB; Feder S; Bickell NA
    J Palliat Care; 2018 Jul; 33(3):143-148. PubMed ID: 29790421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating oncologist variability in prescribing systemic cancer therapies to patients in the last 30 days of life.
    George LS; Duberstein PR; Keating NL; Bates B; Bhagianadh D; Lin H; Saraiya B; Goel S; Akincigil A
    Cancer; 2024 Nov; 130(21):3757-3767. PubMed ID: 39077884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of end-of-life discussions on the reduction of Latino/non-Latino disparities in do-not-resuscitate order completion.
    Shen MJ; Prigerson HG; Paulk E; Trevino KM; Penedo FJ; Tergas AI; Epstein AS; Neugut AI; Maciejewski PK
    Cancer; 2016 Jun; 122(11):1749-56. PubMed ID: 26992109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of a question prompt list to increase patient active participation during interactions with black patients and their oncologists.
    Eggly S; Hamel LM; Foster TS; Albrecht TL; Chapman R; Harper FWK; Thompson H; Griggs JJ; Gonzalez R; Berry-Bobovski L; Tkatch R; Simon M; Shields A; Gadgeel S; Loutfi R; Ali H; Wollner I; Penner LA
    Patient Educ Couns; 2017 May; 100(5):818-826. PubMed ID: 28073615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.